Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

t-GMP Activators

t-GMP activators comprise a diverse group of chemical compounds that indirectly enhance t-GMP's functional activity through modulation of cyclic nucleotide levels and related signaling pathways. Forskolin, by elevating intracellular cAMP, activates PKA, which can phosphorylate substrates involved in t-GMP signaling, thus enhancing t-GMP's functional activity. Similarly, IBMX and Rolipram, as inhibitors of phosphodiesterases, prevent the breakdown of cyclic nucleotides, leading to an accumulation of cAMP (in the case of Rolipram) and both cAMP and cGMP (for IBMX). This accumulation indirectly augments t-GMP activity by increasing its local concentration and promoting its signaling pathways. Furthermore, PDE5 inhibitors like Sildenafil, Vardenafil, and Tadalafil specifically increase cGMP levels, indirectly activating t-GMP through enhanced cGMP-dependent protein kinase signaling pathways. This effect is mirrored by Zaprinast, which selectively inhibits PDE5, leading to increased cGMP levels and subsequent activation of cGMP-dependent pathways related to t-GMP.

The influence on t-GMP activity is further extended by compounds that modulate both cAMP and cGMP levels. Vinpocetine and Papaverine, by inhibiting PDE1, lead to an increase in both these cyclic nucleotides, providing a synergistic enhancement of t-GMP activity through the activation of both cAMP and cGMP-dependent signaling pathways. Cilostazol and Milrinone, as selective PDE3 inhibitors, elevate cAMP levels, which indirectly activates t-GMP through PKA-mediated signaling pathways and the potential cross-talk between cAMP and cGMP signaling. Dipyridamole, with its ability to inhibit various phosphodiesterases, also contributes to the increased levels of cyclic nucleotides, further potentiating t-GMP's functional activity. Collectively, these t-GMP activators, through their targeted effects on cyclic nucleotide levels and signaling pathways, facilitate the enhancement of t-GMP mediated functions, highlighting the intricate interplay between different cellular signaling molecules and pathways in regulating protein activity.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels. Elevated cAMP activates PKA, enhancing t-GMP activity by influencing downstream effectors in t-GMP signaling pathways.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

A non-selective inhibitor of phosphodiesterases. Prevents breakdown of cAMP and cGMP, leading to accumulation of cGMP, which enhances t-GMP activity by promoting its signaling pathways.

Zaprinast (M&B 22948)

37762-06-4sc-201206
sc-201206A
25 mg
100 mg
$105.00
$250.00
8
(2)

Selectively inhibits PDE5, increasing cGMP levels. Elevated cGMP enhances t-GMP activity by activating cGMP-dependent protein kinases (PKG) that influence t-GMP-related pathways.

Vardenafil

224785-90-4sc-362054
sc-362054A
sc-362054B
100 mg
1 g
50 g
$526.00
$735.00
$16653.00
7
(1)

Functions similarly to Sildenafil by inhibiting PDE5 and increasing cGMP levels. This accumulation activates t-GMP via cGMP-dependent signaling mechanisms.

Tadalafil

171596-29-5sc-208412
50 mg
$180.00
13
(2)

Another PDE5 inhibitor that elevates cGMP levels, indirectly activating t-GMP through enhanced cGMP-dependent protein kinase signaling pathways.

Cilostazol

73963-72-1sc-201182
sc-201182A
10 mg
50 mg
$109.00
$322.00
3
(1)

Inhibits PDE3, increasing cAMP levels. Elevated cAMP indirectly activates t-GMP by stimulating PKA, which may modulate proteins in pathways linked to t-GMP activity.

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

A selective PDE4 inhibitor that increases intracellular cAMP levels. This elevation enhances t-GMP activity through PKA-mediated signaling pathways.

Vinpocetine

42971-09-5sc-201204
sc-201204A
sc-201204B
20 mg
100 mg
15 g
$55.00
$214.00
$2400.00
4
(1)

Inhibits PDE1, leading to increased levels of both cAMP and cGMP. This dual elevation synergistically enhances t-GMP activity by activating cAMP and cGMP-dependent pathways.

Dipyridamole

58-32-2sc-200717
sc-200717A
1 g
5 g
$31.00
$102.00
1
(1)

Inhibits various phosphodiesterases, increasing cAMP and cGMP levels. The resultant elevation in cGMP enhances t-GMP activity via cGMP-dependent protein kinases.

Milrinone

78415-72-2sc-201193
sc-201193A
10 mg
50 mg
$165.00
$697.00
7
(0)

Selectively inhibits PDE3, increasing cAMP levels. This increase indirectly enhances t-GMP activity through PKA-mediated pathways and cross-talk between cAMP and cGMP signaling.